Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser for Treating Severe Diabetic Macular Oedema When the Central Retina Goes <400 Microns

NCT06985706 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
264
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Belfast Health and Social Care Trust

Collaborators